Literature DB >> 23816712

Methyl sulfone manifests anticancer activity in a metastatic murine breast cancer cell line and in human breast cancer tissue--part 2: human breast cancer tissue.

Joan McIntyre Caron1, Luke Monteagudo, Melinda Sanders, Marissa Bannon, Peter J Deckers.   

Abstract

BACKGROUND: Methyl sulfone is a small molecule that reverses cancerous phenotypes of a melanoma cell line. Here, we sought to determine whether methyl sulfone was effective against human breast cancer tissue.
METHODS: We studied normal and cancerous breast tissue obtained from 17 patients.
RESULTS: Methyl sulfone introduced structural order, with cancer tissue taking on the morphology of normal in vivo breast tissue; this structural order was sustainable over long-term culture. Methyl sulfone promoted proper wound healing, including migration of cells into wounded areas and establishment of stable contact inhibition once wounds were covered. Methyl sulfone decreased expression of two breast stem cell marker proteins, HCAM and OCT3/4, which are associated with aberrantly rapid migration of metastatic cells. Finally, normal and cancerous primary breast cells remained viable and healthy in methyl sulfone culture for at least 90 days.
CONCLUSION: Methyl sulfone reintroduced a normal structural phenotype to human breast cancer tissues.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23816712     DOI: 10.1159/000351099

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  6 in total

1.  The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts.

Authors:  Nipin S P; Pramod Darvin; Young Beom Yoo; Youn Hee Joung; Dong Young Kang; Don Nam Kim; Tae Sook Hwang; Sang Yoon Kim; Wan Seop Kim; Hak Kyo Lee; Byung Wook Cho; Heui Soo Kim; Kyung Do Park; Jong Hwan Park; Soung Hoon Chang; Young Mok Yang
Journal:  BMC Cancer       Date:  2015-06-19       Impact factor: 4.430

Review 2.  Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement.

Authors:  Matthew Butawan; Rodney L Benjamin; Richard J Bloomer
Journal:  Nutrients       Date:  2017-03-16       Impact factor: 5.717

3.  Iron Metabolism as a Potential Mechanism for Inducing TRAIL-Mediated Extrinsic Apoptosis Using Methylsulfonylmethane in Embryonic Cancer Stem Cells.

Authors:  Nipin Sp; Dong Young Kang; Eun Seong Jo; Jin-Moo Lee; Kyoung-Jin Jang
Journal:  Cells       Date:  2021-10-22       Impact factor: 6.600

Review 4.  Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.

Authors:  Shengming Zhu; Jiangang Wang; Lucas Zellmer; Ningzhi Xu; Mei Liu; Yun Hu; Hong Ma; Fei Deng; Wenxiu Yang; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2022-07-04       Impact factor: 4.478

5.  Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells.

Authors:  Joan McIntyre Caron; Jane McIntyre Caron
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

6.  Methylsulfonylmethane Induces p53 Independent Apoptosis in HCT-116 Colon Cancer Cells.

Authors:  Arzu Zeynep Karabay; Asli Koc; Tulin Ozkan; Yalda Hekmatshoar; Asuman Sunguroglu; Fugen Aktan; Zeliha Buyukbingol
Journal:  Int J Mol Sci       Date:  2016-07-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.